These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30885880)

  • 1. Treatment of severe persistent asthma with IL-6 receptor blockade.
    Esty B; Harb H; Bartnikas LM; Charbonnier LM; Massoud AH; Leon-Astudillo C; Visner G; Subramaniam M; Phipatanakul W; Chatila TA
    J Allergy Clin Immunol Pract; 2019; 7(5):1639-1642.e4. PubMed ID: 30885880
    [No Abstract]   [Full Text] [Related]  

  • 2. Biologic Therapy in a Patient with Asthma and Nasal Polyps.
    Caminati M; Senna G
    J Allergy Clin Immunol Pract; 2019; 7(5):1700-1701. PubMed ID: 31076065
    [No Abstract]   [Full Text] [Related]  

  • 3. Controversies in Allergy: Should Severe Asthma with Eosinophilic Phenotype Always Be Treated with Anti-IL-5 Therapies.
    Pavord ID; Hanania NA
    J Allergy Clin Immunol Pract; 2019; 7(5):1430-1436. PubMed ID: 30962155
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomized, open labeled, comparative study to assess the efficacy and safety of controller medications as add on to inhaled corticosteroid and long-acting β2 agonist in the treatment of moderate-to-severe persistent asthma.
    Patel YA; Patel P; Bavadia H; Dave J; Tripathi CB
    J Postgrad Med; 2010; 56(4):270-4. PubMed ID: 20935397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mepolizumab in the treatment of severe eosinophilic asthma: Results from a physician in the field.
    Strauss RA; Jawhari N
    Ann Allergy Asthma Immunol; 2018 Jul; 121(1):121-123. PubMed ID: 29684570
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of fluticasone/formoterol with budesonide/formoterol pMDI in adults with moderate to severe persistent asthma: Results from a 12-week randomized controlled trial.
    Balki A; Balamurugan S; Bardapurkar S; Dalal S; Singh A; Singh BP; Vaidya A; Gogtay JA
    Pulm Pharmacol Ther; 2018 Feb; 48():28-36. PubMed ID: 28890299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between montelukast and tiotropium as add-on therapy to inhaled corticosteroids plus a long-acting β
    Hoshino M; Akitsu K; Ohtawa J
    J Asthma; 2019 Sep; 56(9):995-1003. PubMed ID: 30212239
    [No Abstract]   [Full Text] [Related]  

  • 8. Asthma and other wheezing disorders in infants and children.
    Keeley D; McKean M
    Clin Evid; 2004 Jun; (11):328-59. PubMed ID: 15652008
    [No Abstract]   [Full Text] [Related]  

  • 9. Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study.
    Simons FE; Villa JR; Lee BW; Teper AM; Lyttle B; Aristizabal G; Laessig W; Schuster A; Perez-Frias J; Sekerel BE; Menten J; Leff JA
    J Pediatr; 2001 May; 138(5):694-8. PubMed ID: 11343045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological and clinical characteristics, spirometric parameters and response to budesonide/formoterol in patients attending an asthma clinic: an experience in a developing country.
    Imad H; Yasir G
    Pan Afr Med J; 2015; 21():154. PubMed ID: 26327991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of asthma therapy alternatives and evaluating the effectivity of asthma therapy by interleukin-13 and interferon gamma levels in children.
    Karaman O; Arli O; Uzuner N; Islekel H; Babayigit A; Olmez D; Kose S; Tezcan D
    Allergy Asthma Proc; 2007; 28(2):204-9. PubMed ID: 17479606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Montelukast for persistent asthma.
    Lipworth BJ; Fowler S; Currie G
    Lancet; 2001 Oct; 358(9291):1455; author reply 1456. PubMed ID: 11705517
    [No Abstract]   [Full Text] [Related]  

  • 13. Montelukast and theophylline: no use or some use in persistent asthma?
    Currie GP; Alluri R; Nair A
    Am J Respir Crit Care Med; 2007 May; 175(10):1094; author reply 1094-5. PubMed ID: 17478625
    [No Abstract]   [Full Text] [Related]  

  • 14. The SIMPLE trial.
    D'Urzo AD
    Can Respir J; 2010; 17(2):56. PubMed ID: 20422059
    [No Abstract]   [Full Text] [Related]  

  • 15. Benralizumab efficacy by atopy status and serum immunoglobulin E for patients with severe, uncontrolled asthma.
    Chipps BE; Newbold P; Hirsch I; Trudo F; Goldman M
    Ann Allergy Asthma Immunol; 2018 May; 120(5):504-511.e4. PubMed ID: 29409951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience with montelukast, a leukotriene receptor antagonist, in pediatric patients with asthma].
    Vega López M; Jiménez Ferral R
    Rev Alerg Mex; 2001; 48(5):133-6. PubMed ID: 11759254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma.
    Katsaounou P; Buhl R; Brusselle G; Pfister P; Martínez R; Wahn U; Bousquet J
    Respir Med; 2019 Apr; 150():51-62. PubMed ID: 30961951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retrospective analysis of omalizumab in patients with severe allergic asthma].
    Padullés Zamora N; Comas Sugrañes D; Méndez Cabaleiro N; Figueras Suriol A; Jodar Masanes R
    Farm Hosp; 2013; 37(5):399-405. PubMed ID: 24128103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intervention Studies of Inhaled Corticosteroids Combined with Long-acting Theophylline or Long-acting β
    Wang Y; Chen P; Dai A; Shang S; Kong L
    Clin Ther; 2016 Dec; 38(12):2622-2627.e1. PubMed ID: 27913032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Importance of leukotriene antagonists in asthma therapy raised].
    MMW Fortschr Med; 2008 Mar; 150(13):44-5. PubMed ID: 18522358
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.